Wed, 03 Apr 2019 07:33:38 GMT
Roche Holding prolongs Spark offer until May
Roche Holding has decided to prolong its $4.3B offer for the US gene therapy company Spark Therapeutics until May 2, after the Swiss drugmaker got only 29.4% of specialist's shares in a deal originally due to complete on Wednesday.